In Brief: Baxter/Corning Clinical Labs
This article was originally published in The Gray Sheet
Executive SummaryBaxter/Corning Clinical Labs: Sign five-year sole-source distribution agreement for Baxter laboratory and diagnostic products which is expected to generate over $200 mil. in sales over the life of the deal. The agreement establishes a "collaborative partnership" between Baxter and CCL and emphasizes product standardization and reduced utilization to cut costs for CCL...
You may also be interested in...
Novartis’s cancer drug has now been filed for multiple sclerosis in the US, armed with a priority review, and in Europe.
Aetion is also working with the US Food and Drug Administration and a number of biopharma companies on projects involving use of real-world evidence.
Increased fines and penalties are on the cards for manufacturing facilities that fail to comply with proposed new requirements.